Skip to content

Effect of plasil on criterias of gastric emptying

The effect of plasil administration on criterias of gastric emptying according to sonography in urgent surgical patients with incomplete NPO time.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20120430009593N12
Enrollment
60
Registered
2020-02-17
Start date
2019-06-22
Completion date
Unknown
Last updated
2020-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aspiration.

Interventions

Intervention 1: As plasil accelerates gastric emptying, we used this drug, which is called metoclopramide, and was administered to patients with vial injection of 4 cc, equivalent to 1 mg in adults.It

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 75 Years

Inclusion criteria

Inclusion criteria: All patients who are admitted to the operating room of Imam Hossein Hospital with an NPO time of fewer than 8 hours for solids or less than 1 hour for clear fluids Have enough time to do ultrasound and study Patient consent after explanation No contraindication for the administration of plasil The patient has the ability to position himself properly for the ultrasound The patient does not have gastrointestinal obstruction The patient has no history of gastric surgery Do not have hyaline rickets The patient has no history of diabetes BMI < 35 The patient has no reflux problem The patient should not be treated with stimulants or gastrointestinal drugs

Exclusion criteria

Exclusion criteria: After administration of plasil or placebo, the patient consumes food or water Vomiting after administration of plasil or placebo

Design outcomes

Primary

MeasureTime frame
Gastric antral grade. Timepoint: Measurement of gastric antrum at baseline and 30 min after injection. Method of measurement: Ultrasound.

Secondary

MeasureTime frame
Decrease in Aspiration Mortality. Timepoint: Gastric antrum measurement at baseline and 30 min after injection. Method of measurement: Ultrasound.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Marzieh Rostami

Shahid Beheshti University of Medical Sciences

marzieh.rostami@yahoo.com+98 21 7755 8001

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026